Victoria Chihai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Victoria Chihai has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Alisa Tabirta
IP Universitatea de Stat de Medicină și Farmacie „Nicolae Testemițanu
3 shared publications - Artiom Jucov
Doctor of Sciences, Director General, National Anti-Doping Agency of the Republic of Moldova; Associate Professor, Department of Family Medicine, Nicolae Testemițanu State University of Medicine and Pharmacy, Republic of Moldova
2 shared publications - Ina Pogonea
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu
2 shared publications - Silvia Stratulat
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu
2 shared publications - Tatiana Timercan
IP Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”; Agenţia Naţională Antidoping
2 shared publications - Adrian Melnic
Universitatea de Stat de Medicină și Farmacie ”Nicolae Testemițanu”;Institutul de Neurologie și Neurochirurgie ”Diomid Gherman
1 shared publication
Latest Publications
- 1 December 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (4) , 93-99
β-adrenergic agonists and β-antagonists in sport performance: a narrative synthesis of pharmacological effects and anti-doping implications
Ntroduction. In the context of increasingly intense athletic competition, athletes are motivated to enhance their performance through various methods, including the use of pharmacological substances that act on the adrenergic system. Among these, β2-adrenergic agonists are employed for their metabolic effects and their role in increasing endurance, whereas β-adrenergic antagonists are used in precision sports to reduce tremor and control anxiety. Both classes of substances present potential benefits as well as health risks, and are subject to strict regulations in high-performance sports. Material and methods. A theoretical study was conducted based on the analysis of specialized scientific literature, aiming to evaluate the impact of β2-adrenergic agonists and β-adrenergic antagonists on athletic performance. Additionally, the current regulations of the World Anti-Doping Agency (WADA) were analyzed. Results. β2-adrenergic agonists may contribute to the stimulation of muscle protein synthesis, enhancement of energy metabolism, and delay in the onset of fatigue. However, their use is associated with significant cardiovascular and metabolic side effects. β-adrenergic antagonists are effective in reducing tremor and sympathetic activation in precision sports but may decrease overall exercise capacity and induce bradycardia or chronic fatigue. Improper use of these substances can lead to severe sanctions in the context of athletic competitions. Conclusions. Although β2-adrenergic agonists and β-adrenergic antagonists may offer certain advantages depending on the specific nature of the sport, their use must be strictly medically regulated and comply with anti-doping standards. Careful evaluation of the risk-benefit ratio is essential for safeguarding athletes' health and preserving the integrity of competition.
- 1 December 2025
- Published by Periodic Publication Moldovan Journal of Health Sciences in Moldovan Journal of Health Sciences
- Vol. 12 (4) , 93-99
β-adrenergic agonists and β-antagonists in sport performance: a narrative synthesis of pharmacological effects and anti-doping implications
Ntroduction. In the context of increasingly intense athletic competition, athletes are motivated to enhance their performance through various methods, including the use of pharmacological substances that act on the adrenergic system. Among these, β2-adrenergic agonists are employed for their metabolic effects and their role in increasing endurance, whereas β-adrenergic antagonists are used in precision sports to reduce tremor and control anxiety. Both classes of substances present potential benefits as well as health risks, and are subject to strict regulations in high-performance sports. Material and methods. A theoretical study was conducted based on the analysis of specialized scientific literature, aiming to evaluate the impact of β2-adrenergic agonists and β-adrenergic antagonists on athletic performance. Additionally, the current regulations of the World Anti-Doping Agency (WADA) were analyzed. Results. β2-adrenergic agonists may contribute to the stimulation of muscle protein synthesis, enhancement of energy metabolism, and delay in the onset of fatigue. However, their use is associated with significant cardiovascular and metabolic side effects. β-adrenergic antagonists are effective in reducing tremor and sympathetic activation in precision sports but may decrease overall exercise capacity and induce bradycardia or chronic fatigue. Improper use of these substances can lead to severe sanctions in the context of athletic competitions. Conclusions. Although β2-adrenergic agonists and β-adrenergic antagonists may offer certain advantages depending on the specific nature of the sport, their use must be strictly medically regulated and comply with anti-doping standards. Careful evaluation of the risk-benefit ratio is essential for safeguarding athletes' health and preserving the integrity of competition.
- Open Access
- 1 December 2024
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 79 (2) , 224-228
The effects of glucocorticosteroids and their specific usage in athletes
Ntroduction. It is well known that, since ancient times, athletes have used various prohibited substances to enhance their physical performance. Glucocorticosteroids, hormonal preparations synthesized by the adrenal glands and their synthetic analogues, are used for their analgesic and anti-inflammatory effects, which can mask the sensation of fatigue. Additionally, these hormones can produce a mildly euphoric state, which may distort the athlete’s true performance. Materials and Methods. The analysis is based on a review of existing literature and studies concerning the use of glucocorticosteroids in sports. The effects of these steroids on physical performance and the impact of their administration. Results. The use of glucocorticosteroids, regardless of the route of administration, is prohibited during sporting competitions. Observed effects include masking the sensation of fatigue and influencing the athlete’s euphoric state, thus providing a distorted view of true performance. Local injections, including intra-articular and peritendinous injections, are included in the list of banned substances. Conclusions. Glucocorticosteroids can significantly impact athletic performance by masking fatigue and inducing an euphoric state. Their use in competitions is strictly regulated. It is essential for athletes and support personnel to be aware of these regulations to ensure the integrity of sporting events.
- 1 December 2024
- Published by Editorial Office "Bulletin of the Academy of Sciences of Moldova. Medical Sciences" in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
- Vol. 79 (2) , 224-228
Open AccessThe effects of glucocorticosteroids and their specific usage in athletes
Ntroduction. It is well known that, since ancient times, athletes have used various prohibited substances to enhance their physical performance. Glucocorticosteroids, hormonal preparations synthesized by the adrenal glands and their synthetic analogues, are used for their analgesic and anti-inflammatory effects, which can mask the sensation of fatigue. Additionally, these hormones can produce a mildly euphoric state, which may distort the athlete’s true performance. Materials and Methods. The analysis is based on a review of existing literature and studies concerning the use of glucocorticosteroids in sports. The effects of these steroids on physical performance and the impact of their administration. Results. The use of glucocorticosteroids, regardless of the route of administration, is prohibited during sporting competitions. Observed effects include masking the sensation of fatigue and influencing the athlete’s euphoric state, thus providing a distorted view of true performance. Local injections, including intra-articular and peritendinous injections, are included in the list of banned substances. Conclusions. Glucocorticosteroids can significantly impact athletic performance by masking fatigue and inducing an euphoric state. Their use in competitions is strictly regulated. It is essential for athletes and support personnel to be aware of these regulations to ensure the integrity of sporting events.
- Open Access
- 1 December 2021
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 4(91)
Medical rehabilitation strategies in complex assistance of people with COVID-19. Literature review
Covid-19 infection is a challenge for the medical system. The development of programs and strategies for the rehabilitation of people in different stages of the disease is relevant and current. The study is a bibliographic synthesis that aimed to analyze the methods and strategies of medical rehabilitation of patients with the new “coronavirus infection”. Data were collected from the academic databases PubMed, PubMed Central, Google, collecting relevant articles from 2019-2021, using the keywords: [“Covid-19” or “Covid 19” or “2019- CoV” or “SARS- CoV” or“ new coronavirus” or “SARS-CoV-2”] and [“rehabilitation ”or“ physical medicine”]. Th e aim of the study was to estimate the consequences of COVID-19 and to identify methods of recovery treatment. Because Covid-19 severely affects the respiratory system, pulmonary rehabilitation interventions with respiratory techniques and postural drainage combined with other physiotherapeutic methods may be used for a patient with COVID-19. The wide range of clinical manifestations in COVID-19 reveals the importance of adapting the rehabilitation program to functional deficits and patient needs. Multifactorial programs combined with active and supportive methods (physical therapy, exercise, occupational therapy, reflex therapy) are effective and can be used in the complex care of patients with COVID-19 at all stages of treatment.
- 1 December 2021
- Published by AO Economie, Management si Psihologie in Medicina in Public Health, Economy and Management in Medicine
- No. 4(91)
Open AccessMedical rehabilitation strategies in complex assistance of people with COVID-19. Literature review
Covid-19 infection is a challenge for the medical system. The development of programs and strategies for the rehabilitation of people in different stages of the disease is relevant and current. The study is a bibliographic synthesis that aimed to analyze the methods and strategies of medical rehabilitation of patients with the new “coronavirus infection”. Data were collected from the academic databases PubMed, PubMed Central, Google, collecting relevant articles from 2019-2021, using the keywords: [“Covid-19” or “Covid 19” or “2019- CoV” or “SARS- CoV” or“ new coronavirus” or “SARS-CoV-2”] and [“rehabilitation ”or“ physical medicine”]. Th e aim of the study was to estimate the consequences of COVID-19 and to identify methods of recovery treatment. Because Covid-19 severely affects the respiratory system, pulmonary rehabilitation interventions with respiratory techniques and postural drainage combined with other physiotherapeutic methods may be used for a patient with COVID-19. The wide range of clinical manifestations in COVID-19 reveals the importance of adapting the rehabilitation program to functional deficits and patient needs. Multifactorial programs combined with active and supportive methods (physical therapy, exercise, occupational therapy, reflex therapy) are effective and can be used in the complex care of patients with COVID-19 at all stages of treatment.